Sinopharm Group Co. Ltd.
SHTDY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $52,124 | $61,667 | $59,787 | $57,736 |
| - Cash | $47,157 | $54,313 | $43,332 | $63,809 |
| + Debt | $93,295 | $76,386 | $101,055 | $73,782 |
| Enterprise Value | $98,262 | $83,740 | $117,510 | $67,709 |
| Revenue | $286,043 | $289,781 | $294,727 | $295,619 |
| % Growth | -1.3% | -1.7% | -0.3% | – |
| Gross Profit | $20,775 | $22,312 | $21,943 | $25,241 |
| % Margin | 7.3% | 7.7% | 7.4% | 8.5% |
| EBITDA | $9,934 | $10,648 | $9,527 | $13,496 |
| % Margin | 3.5% | 3.7% | 3.2% | 4.6% |
| Net Income | $3,458 | $3,346 | $3,704 | $4,949 |
| % Margin | 1.2% | 1.2% | 1.3% | 1.7% |
| EPS Diluted | 5.55 | 5.35 | 5.95 | 7.95 |
| % Growth | 3.7% | -10.1% | -25.2% | – |
| Operating Cash Flow | -$34,111 | $52,540 | -$40,994 | $60,499 |
| Capital Expenditures | -$671 | -$1,438 | -$1,023 | -$1,240 |
| Free Cash Flow | -$34,782 | $51,102 | -$42,017 | $59,259 |